Omega Fund V, L.P. - 05 Apr 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
10%+ Owner
Signature
/s/ Anne-Mari Paster, as an authorized signatory of each Reporting Person
Issuer symbol
NUVB
Transactions as of
05 Apr 2022
Net transactions value
-$14,000,000
Form type
4
Filing time
07 Apr 2022, 16:52:48 UTC
Previous filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Common Stock Sale $14,000,000 -2,500,000 -11% $5.60 20,457,340 05 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Omega Fund V, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.